The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in income, its intellectual property lapse created a deluge of generic competition , significantly eroding its market share . While specific businesses may seek to capitalize on male sexual dysfunction, the